Clinical Pattern of Early-Onset Inflammatory Bowel Disease in Saudi Arabia: A Multicenter National Study.

Inflamm Bowel Dis

*Division of Pediatric Gastroenterology, Children's Specialized Hospital, King Fahad Medical City, University of King Saud Bin Abdulaziz for Health Sciences, Riyadh, Saudi Arabia;†Department of Pediatrics, Gastroenterology Unit, King Saud University, Riyadh, Saudi Arabia;‡Department of Pediatric Gastroenterology, King Abdullah International Medical Research Center, National Guard Hospital-WR, King Saud Bin Abdulaziz University for Health Sceinces, Jeddah, Saudi Arabia;§Section of Pediatric Gastroenterology, Department of Pediatircs, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia;¶Section of Pediatric Gastroenterology, King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia;**Division of Pediatric Gastroenterology, Department of Pediatrics, Inflammatory Bowel Disease Research Group, King Abdulaziz University, Jeddah, Saudi Arabia; and††Division of Pediatric Gastroenterology, Johns Hopkins Aramco Healthcare, Dhahran, Saudi Arabia.

Published: August 2016

Background: The objectives of this multicenter national study were to compare the clinical phenotype of early-onset inflammatory bowel disease (IBD) (EO-IBD) with IBD in older children and to examine whether there is any variability in consanguinity rate and familial aggregation in EO-IBD compared with later onset IBD.

Methods: A retrospective analysis was performed on children aged 0 to 14 years with IBD in 17 centers located in geographically distinct regions in Saudi Arabia, from 2003 to 2012. Data of patients with EO-IBD (0 to <6 yrs) were compared with those with later onset IBD (6-14 yrs). Moreover, we evaluated differences in clinical pattern of infantile or toddler onset IBD subgroup (0-3 yr) as compared with those presenting in older children.

Results: Of 352 IBD patients identified during the 10-year study period, 76 children (21.6%) younger than 6 years were diagnosed with IBD. Among the Crohn's disease (CD) group, infantile or toddler onset CD subgroup showed a more frequent isolated colonic involvement (L2) than later-onset group (57% versus 20%; P = 0.002). Positive family history was significantly more common in the infantile or toddler onset ulcerative colitis subgroup (29.4% versus 4.2% in later onset ulcerative colitis; P < 0.0001). The consanguinity rate was significantly higher in the infantile or toddler onset CD subgroup as compared with later onset CD group (57.1% versus 25.3%; P = 0.04).

Conclusions: In conclusion, EO-IBD exhibits a unique clinical phenotype with a strikingly higher familial aggregation in early-onset ulcerative colitis. Our data suggest a significant genetic impact on the onset of CD in the very young children.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949013PMC
http://dx.doi.org/10.1097/MIB.0000000000000796DOI Listing

Publication Analysis

Top Keywords

early-onset inflammatory
8
inflammatory bowel
8
bowel disease
8
saudi arabia
8
multicenter national
8
national study
8
clinical pattern
4
pattern early-onset
4
disease saudi
4
arabia multicenter
4

Similar Publications

Background: No conceptually new drugs for the safe and successful cure of endometriosis are likely to become available soon. Hormonal modulation of ovarian function and suppression of menstruation remain the pillars of disease control. However, existing drugs may be used following novel modalities to limit the consequences of endometriosis progression.

View Article and Find Full Text PDF

Signal transduction downstream of activating stimuli controls CD8+ T cell biology, however these external inputs can become uncoupled from transcriptional regulation in Primary Immune Regulatory Disorders (PIRDs). Gain-of-function (GOF) variants in STAT3 amplify cytokine signaling and cause a severe PIRD characterized by early onset autoimmunity, lymphoproliferation, recurrent infections, and immune dysregulation. In both primary human and mouse models of STAT3 GOF, CD8+ T cells have been implicated as pathogenic drivers of autoimmunity.

View Article and Find Full Text PDF

C-reactive protein thresholds for discriminating active disease in psoriatic arthritis may be different in early versus established disease.

Clin Exp Rheumatol

December 2024

Rheumatology Division, Central University Hospital of Asturias, Oviedo; Department of Medicine, Oviedo University School of Medicine, Oviedo; and Translational Immunology Division, Biohealth Research Institute of the Principality of Asturias (ISPA), Oviedo, Spain.

Objectives: Inflammatory biomarkers such as C-reactive protein (CRP) lack discriminatory capacity to detect active disease in psoriatic arthritis (PsA). Our aim was to find CRP thresholds capable of discriminating active disease in both early and established PsA.

Methods: We included a total of 345 PsA patients (215 early-onset not exposed to high-impact therapies and 130 with established disease under biologics and oral targeted therapies).

View Article and Find Full Text PDF

Comments on "Inflammatory markers at birth and risk of early onset inflammatory bowel disease".

Gastroenterology

December 2024

Department of General Surgery, Xinqiao Hospital, Army Medical University, Chongqing 400037, China. Electronic address:

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!